Distinct progression patterns across Parkinson disease clinical subtypes.
Journal
Annals of clinical and translational neurology
ISSN: 2328-9503
Titre abrégé: Ann Clin Transl Neurol
Pays: United States
ID NLM: 101623278
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
revised:
18
06
2021
received:
09
04
2021
accepted:
12
07
2021
pubmed:
27
7
2021
medline:
27
1
2022
entrez:
26
7
2021
Statut:
ppublish
Résumé
To examine specific symptom progression patterns and possible disease staging in Parkinson disease clinical subtypes. We recently identified Parkinson disease clinical subtypes based on comprehensive behavioral evaluations, "Motor Only," "Psychiatric & Motor," and "Cognitive & Motor," which differed in dementia and mortality rates. Parkinson disease participants ("Motor Only": n = 61, "Psychiatric & Motor": n = 17, "Cognitive & Motor": n = 70) and controls (n = 55) completed longitudinal, comprehensive motor, cognitive, and psychiatric evaluations (average follow-up = 4.6 years). Hierarchical linear modeling examined group differences in symptom progression. A three-way interaction among time, group, and symptom duration (or baseline age, separately) was incorporated to examine disease stages. All three subtypes increased in motor dysfunction compared to controls. The "Motor Only" subtype did not show significant cognitive or psychiatric changes compared to the other two subtypes. The "Cognitive & Motor" subtype's cognitive dysfunction at baseline further declined compared to the other two subtypes, while also increasing in psychiatric symptoms. The "Psychiatric & Motor" subtype's elevated psychiatric symptoms at baseline remained steady or improved over time, with mild, steady decline in cognition. The pattern of behavioral changes and analyses for disease staging yielded no evidence for sequential disease stages. Parkinson disease clinical subtypes progress in clear, temporally distinct patterns from one another, particularly in cognitive and psychiatric features. This highlights the importance of comprehensive clinical examinations as the order of symptom presentation impacts clinical prognosis.
Identifiants
pubmed: 34310084
doi: 10.1002/acn3.51436
pmc: PMC8351397
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1695-1708Subventions
Organisme : NINDS NIH HHS
ID : K08 NS048924
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR024992
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS075321
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS041509
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS058714
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002345
Pays : United States
Organisme : NINDS NIH HHS
ID : RF1 NS075321
Pays : United States
Organisme : NINDS NIH HHS
ID : P30 NS048056
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS097437
Pays : United States
Informations de copyright
© 2021 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
Références
Neurosci Biobehav Rev. 2009 Jun;33(6):926-52
pubmed: 19428501
J Neurol Neurosurg Psychiatry. 2013 Nov;84(11):1258-64
pubmed: 23781007
Parkinsonism Relat Disord. 2013 Feb;19(2):218-21
pubmed: 23102808
Neurology. 1990 Oct;40(10):1529-34
pubmed: 2215943
Br J Psychiatry. 1982 Jun;140:566-72
pubmed: 7104545
Neurotoxicology. 2006 May;27(3):357-61
pubmed: 16376428
J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
pubmed: 1564476
Arch Neurol. 2010 Aug;67(8):996-1001
pubmed: 20697051
J Psychiatr Res. 1982-1983;17(1):37-49
pubmed: 7183759
Arch Neurol. 2003 Mar;60(3):387-92
pubmed: 12633150
Trends Neurosci. 2000 Sep;23(9):412-7
pubmed: 10941190
Mov Disord. 2009 Oct 30;24(14):2081-90
pubmed: 19691116
Mov Disord. 2010 Nov 15;25(15):2516-23
pubmed: 20922808
Neurology. 2020 Sep 15;95(11):e1445-e1460
pubmed: 32817178
Neurology. 2018 Nov 27;91(22):e2045-e2056
pubmed: 30381367
Parkinsonism Relat Disord. 2014 Sep;20(9):980-5
pubmed: 25024059
Mov Disord. 2010 Nov 15;25(15):2649-53
pubmed: 21069833
Hum Brain Mapp. 2018 Dec;39(12):5014-5027
pubmed: 30259598
J Affect Disord. 2015 Jul 15;180:179-84
pubmed: 25911132
Assessment. 1999 Sep;6(3):269-84
pubmed: 10445964
JAMA Neurol. 2019 Apr 1;76(4):470-479
pubmed: 30640364
Ann Clin Transl Neurol. 2020 Aug;7(8):1272-1283
pubmed: 32602253
Mov Disord. 2016 Jul;31(7):957-61
pubmed: 27226220
Mov Disord. 1999 Jan;14(1):10-20
pubmed: 9918339
Mov Disord. 2013 Jun;28(6):755-62
pubmed: 23520046
Parkinsonism Relat Disord. 2016 Jul;28:130-6
pubmed: 27215393
Neurology. 1994 Dec;44(12):2308-14
pubmed: 7991117
Maturitas. 2014 Oct;79(2):184-90
pubmed: 24931304
Mov Disord. 1995 May;10(3):329-32
pubmed: 7651451
Neurology. 2010 Oct 5;75(14):1270-6
pubmed: 20921512
Mov Disord. 2011 Jan;26(1):51-8
pubmed: 21322019
Mov Disord. 2014 Jan;29(1):150-1
pubmed: 24038593
Neurology. 2002 Aug 13;59(3):408-13
pubmed: 12177375
JAMA Neurol. 2015 Aug;72(8):863-73
pubmed: 26076039
PLoS One. 2013 Aug 01;8(8):e70244
pubmed: 23936396